华润双鹤(600062.SH)：子公司京西双鹤复方醋酸钠林格注射液获得药品注册证书

Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. has received a drug registration certificate from the National Medical Products Administration for its Sodium Acetate Compound Injection, indicating a significant regulatory approval for the company’s product line [1] Group 1: Company Developments - The wholly-owned subsidiary, Xi'an Jingxi Double Crane Pharmaceutical Co., Ltd., is responsible for the newly approved Sodium Acetate Compound Injection [1] - The Sodium Acetate Compound Injection is indicated for the replenishment of extracellular fluid in cases of reduced circulating blood volume and interstitial fluid, as well as for the correction of metabolic acidosis [1]